Is Calithera Biosciences Inc (CALA) a Stock to Watch After Losing -2.78% This Week?

Wednesday, April 20, 2022 01:48 PM | InvestorsObserver Analysts

Mentioned in this article

Is Calithera Biosciences Inc (CALA) a Stock to Watch After Losing -2.78% This Week?

Overall market sentiment has been high on Calithera Biosciences Inc (CALA) stock lately. CALA receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.

Calithera Biosciences Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on CALA!

See Full CALA Report

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With CALA Stock Today?

Calithera Biosciences Inc (CALA) stock is down -2.97% while the S&P 500 is up 0.4% as of 1:47 PM on Wednesday, Apr 20. CALA is lower by -$0.01 from the previous closing price of $0.36 on volume of 3,521,162 shares. Over the past year the S&P 500 has gained 7.61% while CALA is lower by -83.80%. CALA lost -$1.56 per share in the over the last 12 months. To screen for more stocks like Calithera Biosciences Inc click here.

More About Calithera Biosciences Inc

Calithera Biosciences Inc is a clinical-stage pharmaceutical company. The business activity of the firm is functioned through the region of US. It focuses on discovering and developing small molecule drugs directed against tumor and immune cell targets that control key metabolic pathways in the tumor microenvironment. Its lead product candidate is CB-839, an inhibitor of glutaminase for the treatment of solid tumors. Its other product candidate, CB-1158, is being developed for hematology and oncology indications. Click Here to get the full Stock Report for Calithera Biosciences Inc stock.